HomeCompareCDXFF vs ABBV

CDXFF vs ABBV: Dividend Comparison 2026

CDXFF yields 2116.40% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDXFF wins by $16850188636.03M in total portfolio value
10 years
CDXFF
CDXFF
● Live price
2116.40%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$16850188636.07M
Annual income
$15,417,192,906,367,192.00
Full CDXFF calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — CDXFF vs ABBV

📍 CDXFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDXFFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDXFF + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
CDXFF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDXFF
Annual income on $10K today (after 15% tax)
$179,894.18/yr
After 10yr DRIP, annual income (after tax)
$13,104,613,970,412,112.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, CDXFF beats the other by $13,104,613,970,411,130.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDXFF + ABBV for your $10,000?

CDXFF: 50%ABBV: 50%
100% ABBV50/50100% CDXFF
Portfolio after 10yr
$8425094318.05M
Annual income
$7,708,596,453,184,173.00/yr
Blended yield
91.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

CDXFF
No analyst data
Altman Z
-67.9
Piotroski
3/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDXFF buys
0
ABBV buys
0
No recent congressional trades found for CDXFF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDXFFABBV
Forward yield2116.40%3.67%
Annual dividend / share$2.00$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR0%8.9%
Portfolio after 10y$16850188636.07M$39.9K
Annual income after 10y$15,417,192,906,367,192.00$1,154.43
Total dividends collected$16748912801.47M$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CDXFF vs ABBV ($10,000, DRIP)

YearCDXFF PortfolioCDXFF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$222,340$211,640.21$11,520$399.75+$210.8KCDXFF
2$4,635,673$4,397,769.11$13,261$450.98+$4.62MCDXFF
3$90,652,793$85,692,623.21$15,255$508.41+$90.64MCDXFF
4$1,663,129,343$1,566,130,853.69$17,536$572.74+$1663.11MCDXFF
5$28,632,319,033$26,852,770,636.14$20,145$644.78+$28632.30MCDXFF
6$462,688,385,745$432,051,804,380.31$23,126$725.38+$462688.36MCDXFF
7$7,020,130,708,021$6,525,054,135,273.67$26,532$815.52+$7020130.68MCDXFF
8$100,036,081,369,040$92,524,541,511,456.90$30,420$916.26+$100036081.34MCDXFF
9$1,339,248,345,515,456$1,232,209,738,450,583.50$34,855$1,028.80+$1339248345.48MCDXFF
10$16,850,188,636,068,730$15,417,192,906,367,192.00$39,914$1,154.43+$16850188636.03MCDXFF

CDXFF vs ABBV: Complete Analysis 2026

CDXFFStock

Cloud DX Inc. operates as a remote patient monitoring company. It offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including chronic obstructive pulmonary disease and congestive heart failure, as well as patients recovering from surgery and COVID-19 patients outside hospitals. The company's Cloud DX Connected Health Kits includes its Cloud DX Bluetooth pulse oximeter, the Cloud DX wireless weight scale and optionally, a wireless Bluetooth blood pressure monitor, digital thermometer, and digital wireless glucose meter from 3rd party suppliers. It serves academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company also offers VITALITI, a vital sign monitor for measuring electrocardiograph, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Brooklyn, New York.

Full CDXFF Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this CDXFF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDXFF vs SCHDCDXFF vs JEPICDXFF vs OCDXFF vs KOCDXFF vs MAINCDXFF vs JNJCDXFF vs MRKCDXFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.